QQQ   382.55 (+1.22%)
AAPL   149.40 (+0.51%)
MSFT   310.32 (+0.71%)
FB   322.12 (-2.00%)
GOOGL   2,774.21 (+0.92%)
TSLA   1,093.23 (+6.67%)
AMZN   3,412.42 (+2.77%)
NVDA   250.99 (+8.34%)
BABA   172.03 (-2.35%)
NIO   41.99 (+1.74%)
CGC   13.54 (-0.22%)
GE   107.82 (+2.39%)
AMD   126.05 (+3.02%)
MU   69.17 (+0.60%)
T   25.59 (-0.20%)
F   15.99 (-0.06%)
ACB   7.12 (-0.84%)
DIS   172.92 (+0.53%)
PFE   43.28 (+0.30%)
BA   213.28 (+0.19%)
AMC   36.36 (-1.28%)
QQQ   382.55 (+1.22%)
AAPL   149.40 (+0.51%)
MSFT   310.32 (+0.71%)
FB   322.12 (-2.00%)
GOOGL   2,774.21 (+0.92%)
TSLA   1,093.23 (+6.67%)
AMZN   3,412.42 (+2.77%)
NVDA   250.99 (+8.34%)
BABA   172.03 (-2.35%)
NIO   41.99 (+1.74%)
CGC   13.54 (-0.22%)
GE   107.82 (+2.39%)
AMD   126.05 (+3.02%)
MU   69.17 (+0.60%)
T   25.59 (-0.20%)
F   15.99 (-0.06%)
ACB   7.12 (-0.84%)
DIS   172.92 (+0.53%)
PFE   43.28 (+0.30%)
BA   213.28 (+0.19%)
AMC   36.36 (-1.28%)
QQQ   382.55 (+1.22%)
AAPL   149.40 (+0.51%)
MSFT   310.32 (+0.71%)
FB   322.12 (-2.00%)
GOOGL   2,774.21 (+0.92%)
TSLA   1,093.23 (+6.67%)
AMZN   3,412.42 (+2.77%)
NVDA   250.99 (+8.34%)
BABA   172.03 (-2.35%)
NIO   41.99 (+1.74%)
CGC   13.54 (-0.22%)
GE   107.82 (+2.39%)
AMD   126.05 (+3.02%)
MU   69.17 (+0.60%)
T   25.59 (-0.20%)
F   15.99 (-0.06%)
ACB   7.12 (-0.84%)
DIS   172.92 (+0.53%)
PFE   43.28 (+0.30%)
BA   213.28 (+0.19%)
AMC   36.36 (-1.28%)
QQQ   382.55 (+1.22%)
AAPL   149.40 (+0.51%)
MSFT   310.32 (+0.71%)
FB   322.12 (-2.00%)
GOOGL   2,774.21 (+0.92%)
TSLA   1,093.23 (+6.67%)
AMZN   3,412.42 (+2.77%)
NVDA   250.99 (+8.34%)
BABA   172.03 (-2.35%)
NIO   41.99 (+1.74%)
CGC   13.54 (-0.22%)
GE   107.82 (+2.39%)
AMD   126.05 (+3.02%)
MU   69.17 (+0.60%)
T   25.59 (-0.20%)
F   15.99 (-0.06%)
ACB   7.12 (-0.84%)
DIS   172.92 (+0.53%)
PFE   43.28 (+0.30%)
BA   213.28 (+0.19%)
AMC   36.36 (-1.28%)
CVE:RVV

Revive Therapeutics Stock Forecast, Price & News

C$0.08
+0.01 (+14.29 %)
(As of 07/22/2019)
Add
Compare
Today's Range
C$0.08
C$0.09
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.07
C$0.25
Volume212,852 shs
Average Volume93,085 shs
Market CapitalizationC$5.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RVV News and Ratings via Email

Sign-up to receive the latest news and ratings for Revive Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


About Revive Therapeutics

Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.03 per share
Book Value
C$0.02 per share

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
C$5.79 million
Next Earnings Date
11/26/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.21 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Revive Therapeutics (CVE:RVV) Frequently Asked Questions

What stocks does MarketBeat like better than Revive Therapeutics?

Wall Street analysts have given Revive Therapeutics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Revive Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Revive Therapeutics' next earnings date?

Revive Therapeutics is scheduled to release its next quarterly earnings announcement on Friday, November 26th 2021.
View our earnings forecast for Revive Therapeutics
.

Who are Revive Therapeutics' key executives?

Revive Therapeutics' management team includes the following people:
  • Mr. Craig Leon, Chairman & CEO (Age 51)
  • Mr. Fabio Chianelli, Pres & Director (Age 41)
  • Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48)

What other stocks do shareholders of Revive Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Revive Therapeutics investors own include Heat Biologics (HTBX), The Green Organic Dutchman (TGOD), Aurora Cannabis (ACB), CytoDyn (CYDY), Genprex (GNPX), iBio (IBIO), Sorrento Therapeutics (SRNE), Workhorse Group (WKHS), Acasti Pharma (ACST) and Anavex Life Sciences (AVXL).

What is Revive Therapeutics' stock symbol?

Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."

How do I buy shares of Revive Therapeutics?

Shares of RVV and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Revive Therapeutics' stock price today?

One share of RVV stock can currently be purchased for approximately C$0.08.

How much money does Revive Therapeutics make?

Revive Therapeutics has a market capitalization of C$5.79 million.

What is Revive Therapeutics' official website?

The official website for Revive Therapeutics is www.revivethera.com.

Where are Revive Therapeutics' headquarters?

Revive Therapeutics is headquartered at 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada.

How can I contact Revive Therapeutics?

Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.